Prime Highlights-
- Emerald secures €1.66 million, combining an Innovate UK grant and venture capital, to expand its preventive healthcare platform and develop AI technology.
- The London-based startup targets one million members over the next three years after membership grew tenfold since the start of 2026.
Key Facts-
- Funding includes an €832,200 Innovate UK grant and €832,200 in venture capital investment.
- Emerald has processed over 100,000 laboratory tests, lifting total funding to €3.44 million.
Background-
London-based preventive healthcare platform Emerald has raised a further €1.66 million (£1.4 million), lifting its total funding to €3.44 million (£2.9 million).
The round includes an €832,200 (£700,000) grant from Innovate UK, the company’s second award from the agency, and a matching €832,200 in venture capital raised after the grant. All existing investors took part, joined by new backers Sequel and Highgoal, and the company’s valuation rose from its previous round.
Emerald will use the money to expand its services, build AI technology and reach more patients. It targets one million members over the next three years. The Innovate UK grant will specifically support its AI applications and underlying technology.
Founded in 2024, Emerald combines clinic-based laboratory screening with a digital platform that gathers test results, wearable data and health histories. Members get a GP who can diagnose conditions, prescribe treatments and refer patients to private or NHS services. The company is registered with the Care Quality Commission and holds UKCA Class I medical device authorization from the MHRA.
Emerald says membership has grown tenfold since the start of 2026 and the platform has processed more than 100,000 laboratory tests. Repeat screening shows better cholesterol in two of three users, blood sugar down by a third and inflammation down by almost half.
Alexander Badalyan, co-founder and chief executive, said demand is growing for simple healthcare tools that go beyond testing and explain what results mean.
Chris Sawyer, innovation lead for digital health at Innovate UK, said the award backs AI technology that helps clinicians deliver more personalized, proactive care.
